Bikash Ranjan Mandal

Bikash Ranjan Mandal

Active Director Managing Director DIN 06921417
DIN 06921417 First appointment May 2015 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Bikash Ranjan Mandal

Data last updated:

Bikash Ranjan Mandal is a Managing Director at Ritik Medicare Private Limited (since 2015). The company operates in Chemicals.

DIN 06921417
Primary Designation Managing Director
Industry Chemicals
First Appointment 22 May 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ritik Medicare Private Limited U33130GJ2015PTC083281
Managing Director22 May 20152015Active

Board colleagues of Bikash Ranjan Mandal

NameDINCompanyDesignation
Kamalika Mandal06921426Ritik Medicare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ritik Medicare Private Limited
Premium access

Shareholding and investment profile for Bikash Ranjan Mandal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bikash Ranjan Mandal

Bikash Ranjan Mandal currently holds 1 directorship: Ritik Medicare Private Limited (Managing Director, since 22 May 2015).

Bikash Ranjan Mandal was first appointed on 22 May 2015 as Managing Director at Ritik Medicare Private Limited.

The current boards of Bikash Ranjan Mandal's companies include Kamalika Mandal (Ritik Medicare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available